Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,092
Closed -$796K 2048
2025
Q2
$796K Sell
8,092
-1,146
-12% -$108K ﹤0.01% 1136
2025
Q1
$856K Buy
+9,238
New +$852K 0.01% 1037
2024
Q1
Sell
-2,993
Closed -$285K 1662
2023
Q4
$285K Sell
2,993
-550
-16% -$51.4K 0.01% 1189
2023
Q3
$331K Sell
3,543
-156
-4% -$14.4K 0.01% 1024
2023
Q2
$338K Buy
3,699
+449
+14% +$36.8K 0.01% 988
2023
Q1
$239K Buy
+3,250
New +$281K 0.01% 1108

Other funds holding AMED

Tidal Investments's AMED Position: Q3 2025 in Review

Tidal Investments sold out of Amedisys (AMED) in Q3 2025, closing a stake of 8,092 shares — an estimated $796K sold.

Tidal Investments first reported a position in AMED in Q1 2023 and held it in 6 quarters. The position peaked at $856K in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Tidal Investments reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Tidal Investments sold 8,092 Amedisys shares in Q3 2025, an estimated $796K.
  • Tidal Investments first reported a position in Amedisys in Q1 2023 and held it in 6 quarters.
  • Tidal Investments's Amedisys position peaked at $856K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Tidal Investments's 13F filing for Q3 2025, filed 14 Nov 2025.